How Letrozole Affects Estradiol

Letrozole is a non-steroidal, competitive aromatase inhibitor. Like anastrozole, it binds reversibly to the CYP19A1 (aromatase) enzyme and blocks the conversion of testosterone to estradiol.

What sets it apart:

• It is generally regarded as the most potent of the three common AIs, based mainly on data in women. In postmenopausal women, the label reports 75-95% estrogen suppression, with maximal suppression within two to three days
• In healthy men, 2.5 mg a day for 28 days lowered free estradiol by 46% in young men and 62% in older men (10 men per group), while LH rose by more than 300% and testosterone rose by 99-146% (T'Sjoen et al., 2005)
• Estradiol in men directly controls the brake on LH and FSH, so suppressing it releases the axis in men who still produce their own testosterone (Raven et al., 2006)

Pharmacokinetics:

• Terminal half-life of about 2 days (label)
• Steady state takes 2-6 weeks of daily dosing, so the effect keeps building for weeks after starting
• The inhibition is reversible, but the long half-life and slow build-up mean washout takes longer than anastrozole

Studied dose (2.5 mg daily):

• Estradiol falls by roughly half in young men and by about two thirds in older men within four weeks
• On TRT or a cycle, the testis is suppressed and cannot respond with more testosterone, so the fall may go deeper than in these trials. This is a reasonable inference, not a measured result

Low "maintenance" doses used in bodybuilding (fractions of a tablet):

• No controlled data exists for these regimens in men. Given letrozole's potency and slow build-up, small doses can still accumulate into a crash over several weeks

Time course:

• Suppression is near maximal within days, then deepens as the drug accumulates toward steady state
• After stopping, expect estradiol to take roughly 2-3 weeks to recover, longer after extended use. This is derived from the half-life and label data; no study has measured recovery in men

Before starting: Letrozole should only be used with a confirmed high estradiol on a sensitive (LC-MS/MS) assay, ideally under medical supervision. The standard immunoassay reads falsely high in men and can lead to unnecessary AI use.

While using: Recheck sensitive estradiol within 2 weeks. Because steady state takes 2-6 weeks, a normal result early on does not mean the dose is safe long term; recheck again at 4-6 weeks.

After stopping: Wait at least 2 weeks before retesting to judge recovery.

Symptoms to watch: Low or absent libido, softer erections, flat mood, fatigue, and dry or aching joints. Bone loss from low estradiol is silent, so do not rely on symptoms alone.

Use it as a rescue drug, not a routine AI:

• Letrozole is used off-label for established gynecomastia flare-ups. For routine estrogen control on TRT, a lower testosterone dose, more frequent injections or a low-dose reversible AI are far easier to manage
• Never combine letrozole with EQ (boldenone), which already tends to suppress estradiol

If estradiol has crashed on letrozole:

• Stop it. Do not add another compound to compensate
• Retest sensitive estradiol after 2-3 weeks
• If testosterone is low relative to the rest of the stack, a higher aromatisable testosterone base helps estradiol recover

Further reading: How to fix crashed E2 on TRT or cycle